Shares of Resverlogix Corp. (TSE:RVX – Get Free Report) crossed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of C$0.11 and traded as high as C$0.11. Resverlogix shares last traded at C$0.10, with a volume of 34,500 shares trading hands.
Resverlogix Stock Performance
The company has a debt-to-equity ratio of -81.94, a current ratio of 0.04 and a quick ratio of 0.04. The firm has a fifty day moving average price of C$0.11 and a two-hundred day moving average price of C$0.11. The stock has a market capitalization of C$31.62 million, a PE ratio of -3.33 and a beta of 0.70.
About Resverlogix
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Featured Articles
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
